Recombinant multi-species RIT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RIT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a subfamily of Ras-related GTPases. The encoded protein is involved in regulating p38 MAPK-dependent signaling cascades related to cellular stress. This protein also cooperates with nerve growth factor to promote neuronal development and regeneration. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
The Alternative Names of target: GTP-binding protein Rit1,NS8,RGD1559874,RIBB,RIT,RIT1,ROC1,Ras-like protein expressed in many tissues,Ras-like without CAAX protein 1,Rit,Rit1

Target products collectionGo to RIT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10910-Ag-1/ GM-Tg-hg-IP10910-Ag-2 Human RIT1 protein Human
GM-Tg-rg-IP10910-Ag-1/ GM-Tg-rg-IP10910-Ag-2 Rat RIT1 protein Rat
GM-Tg-mg-IP10910-Ag-1/ GM-Tg-mg-IP10910-Ag-2 Mouse RIT1 protein Mouse
GM-Tg-cynog-IP10910-Ag-1/ GM-Tg-cynog-IP10910-Ag-2 Cynomolgus/Rhesus macaque RIT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10910-Ag-1/ GM-Tg-felg-IP10910-Ag-2 Feline RIT1 protein Feline
GM-Tg-cang-IP10910-Ag-1/ GM-Tg-cang-IP10910-Ag-2 Canine RIT1 protein Canine
GM-Tg-bovg-IP10910-Ag-1/ GM-Tg-bovg-IP10910-Ag-2 Bovine RIT1 protein Bovine
GM-Tg-equg-IP10910-Ag-1/ GM-Tg-equg-IP10910-Ag-2 Equine RIT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10910-Ag-1/ GM-Tg-hg-IP10910-Ag-2; GM-Tg-rg-IP10910-Ag-1/ GM-Tg-rg-IP10910-Ag-2;
GM-Tg-mg-IP10910-Ag-1/ GM-Tg-mg-IP10910-Ag-2; GM-Tg-cynog-IP10910-Ag-1/ GM-Tg-cynog-IP10910-Ag-2;
GM-Tg-felg-IP10910-Ag-1/ GM-Tg-felg-IP10910-Ag-2; GM-Tg-cang-IP10910-Ag-1/ GM-Tg-cang-IP10910-Ag-2;
GM-Tg-bovg-IP10910-Ag-1/ GM-Tg-bovg-IP10910-Ag-2; GM-Tg-equg-IP10910-Ag-1/ GM-Tg-equg-IP10910-Ag-2
Products Name RIT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RIT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RIT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.